Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q3FY25 of ₹2,809.00 Crores up from ₹2,732.00 Crore year on year, a rise of 2.82%.
Total Expenses for Q3FY25 of ₹2,151.00 Crores down from ₹2,156.00 Crores year on year, a fall of 0.23%.
Consolidated Net Profit of ₹503.00 Crores up 13.54% from ₹443.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹14.86, up 13.52% from ₹13.09 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="772px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
